---
title: "Waters Corporation (WAT.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/WAT.US.md"
symbol: "WAT.US"
name: "Waters Corporation"
industry: "Life Sciences Tools and Services"
datetime: "2026-06-10T08:25:57.203Z"
locales:
  - [en](https://longbridge.com/en/quote/WAT.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/WAT.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/WAT.US.md)
---

# Waters Corporation (WAT.US)

## Company Overview

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates through two segments, Waters and TA. The company designs, manufactures, sells, and services liquid chromatography, as well as mass spectrometry (MS) technology systems and supports products, including chromatography columns, and other consumable products. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer goods, and healthcare products, as well as for life science research; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments.

| Item | Detail |
|------|--------|
| Industry | Life Sciences Tools and Services |
| Exchange | US Market |
| Website | [www.waters.com](https://www.waters.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-06-10T04:30:17.000Z

**Overall: C (0.41)**

**Industry**: Life Sciences Tools and Services

| Metric | Value |
|--------|-------|
| Industry Ranking | 14 / 60 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Large - The company has stable operations, allowing for dependable long-term returns.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 26.37% |  |
| Net Profit YoY | -31.53% |  |
| P/B Ratio | 2.38 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 36441680083.25 |  |
| Revenue | 3770286000.00 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 5.21% | C |
| Profit Margin | 11.93% | B |
| Gross Margin | 46.41% | B |
| Revenue YoY | 26.37% | A |
| Net Profit YoY | -31.53% | D |
| Total Assets YoY | 434.26% | A |
| Net Assets YoY | 679.25% | A |
| Cash Flow Margin | 86.64% | C |
| OCF YoY | 26.37% | A |
| Turnover | 0.26 | D |
| Gearing Ratio | 37.66% | B |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Waters Corporation",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "26.37%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-31.53%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "2.38",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "36441680083.25",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "3770286000.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "5.21%",
          "rating": "C"
        },
        {
          "name": "Profit Margin",
          "value": "11.93%",
          "rating": "B"
        },
        {
          "name": "Gross Margin",
          "value": "46.41%",
          "rating": "B"
        },
        {
          "name": "Revenue YoY",
          "value": "26.37%",
          "rating": "A"
        },
        {
          "name": "Net Profit YoY",
          "value": "-31.53%",
          "rating": "D"
        },
        {
          "name": "Total Assets YoY",
          "value": "434.26%",
          "rating": "A"
        },
        {
          "name": "Net Assets YoY",
          "value": "679.25%",
          "rating": "A"
        },
        {
          "name": "Cash Flow Margin",
          "value": "86.64%",
          "rating": "C"
        },
        {
          "name": "OCF YoY",
          "value": "26.37%",
          "rating": "A"
        },
        {
          "name": "Turnover",
          "value": "0.26",
          "rating": "D"
        },
        {
          "name": "Gearing Ratio",
          "value": "37.66%",
          "rating": "B"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 81.05 | 20/60 | 47.33 | 34.85 | 27.47 |
| PB | 2.38 | 24/60 | 11.20 | 9.70 | 8.18 |
| PS (TTM) | 9.67 | 50/60 | 9.29 | 7.28 | 6.02 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | ChromaDex (CDXC.US) | A | A | A | B | A | A |
| 02 | Agilent Tech (A.US) | A | B | B | C | C | B |
| 03 | Illumina (ILMN.US) | A | C | B | D | C | B |
| 04 | West Pharmaceutical (WST.US) | B | B | B | B | B | B |
| 05 | WuXi Biologics (WXXWY.US) | B | B | C | A | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-06-03T04:00:00.000Z

Total Analysts: **22**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 12 | 55% |
| Overweight | 2 | 9% |
| Hold | 8 | 36% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 371.15 |
| Highest Target | 460.00 |
| Lowest Target | 345.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/WAT.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/WAT.US/norm.md)
- [Related News](https://longbridge.com/en/quote/WAT.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/WAT.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**